We served as regulatory counsel to Paragon healthcare, Inc., a leading provider of infusion services to patients, in its sale to Elevance Health (NYSE: ELV), a diverse portfolio of industry-leading medical, digital, pharmacy, behavioral, clinical, and complex care solutions. Terms of the transaction were not disclosed.